ArticleFrontiers in pediatrics2026
Integrated single-cell and bulk-tissue transcriptomic analysis reveals an epithelial-stromal inflammatory microenvironment in biliary atresia.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Biliary atresia is a severe fibroinflammatory cholangiopathy of infancy. Its pathological process involves biliary epithelial injury, immune activation, and intrahepatic stromal remodeling, but the cellular interactions linking these processes remain incompletely defined. Using public single-cell and bulk-tissue transcriptomic cohorts, this study systematically characterized disease-associated alterations across liver cell populations in biliary atresia and further evaluated their consistency in independent cohorts. Methods: Public single-cell liver data (GSE176189) and three independent bulk-tissue cohorts (GSE122340, GSE300457, and GSE46960) were analyzed. The single-cell cohort contained 119,538 cells after filtering, including 89,118 cells from biliary atresia samples and 30,420 cells from choledochal cyst samples. Disease-associated genes were identified within major cell populations, used to construct cell-origin microenvironment signatures, and evaluated across bulk cohorts. Results: Broad cell-type annotation identified cholangiocytes, macrophages, T cells, endothelial cells, fibroblasts, and other liver-resident or immune populations. Based on biliary atresia-upregulated genes from five key cell populations, a 219-gene pathological microenvironment signature was constructed. Cell-type-specific enrichment analysis highlighted immune, antiviral, migration, and matrix-related biological processes, although the fibroblast component was based on fewer genes and was interpreted cautiously. In three bulk-tissue cohorts, the composite microenvironment score was elevated in biliary atresia samples, with areas under the receiver operating characteristic curve of 0.993, 0.782, and 0.798, respectively. Cell-communication analysis suggested candidate MIF, GALECTIN, CLEC, PTN, NOTCH, and CXCL signaling axes, which require spatial or experimental validation. Conclusion: These findings support a multi-cellular inflammatory microenvironment in biliary atresia liver and nominate epithelial-immune-stromal communication axes for future validation, while recognizing that the single-cell comparison used choledochal cyst rather than normal liver as the control condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.